Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts - Moon, J; Lee, S Y; Choi, J W; Lee, A R; Yoo, J H; Moon, S J; Park, S H; Cho, M L (J Transl Med, 2021)